Surgical Microscope Market Size, Research, Analysis (1) - PowerPoint PPT Presentation

About This Presentation
Title:

Surgical Microscope Market Size, Research, Analysis (1)

Description:

The Asia Pacific cancer screening market is estimated to garner a revenue of USD 142542.43 Million by the end of 2030, by growing at a CAGR of 13.37% over the forecast period, i.e., 2021 – 2030. – PowerPoint PPT presentation

Number of Views:9

less

Transcript and Presenter's Notes

Title: Surgical Microscope Market Size, Research, Analysis (1)


1
Asia Pacific Cancer Screening Market to Grow on
the Back of Growing Incidences of Cancer in the
Region Market to Grow with a CAGR of 13.37
During 2021-2030 Kenneth Research has released a
report titled Asia Pacific Cancer Screening
Market Demand Analysis Opportunity Outlook
2030 which also includes some of the prominent
market analyzing parameters such as industry
growth drivers, restraints, supply and demand
risk, along with the impact of COVID-19 and a
detailed discussion on the latest trends and
future opportunities that are associated with the
growth of the market. The incidence of cancer in
the Asia Pacific, according to the statistics by
the World Health Organization (WHO), is
projected to touch 15.1 Million by the end of
2040. Moreover, in the year 2020, the incidence
of the disease was recorded to be 9.50 Million.
Request sample reporthttps//www.kennethresearch.
com/sample- request-10352360
2
The statistics portray the growing incidences of
cancer cases in the Asia Pacific, which is
raising the need amongst the individuals for the
early detection and diagnosis of the disease.
With the help of cancer screening devices and
processes, different types of cancer disease can
be identified at a very early stage, thereby
helping the healthcare service providers to
prescribe the right medicine to their patients at
the right time. Such a factor is anticipated to
drive the growth of the Asia Pacific cancer
screening market in the coming years. The Asia
Pacific cancer screening market is anticipated to
grow with a CAGR of 13.37 during the forecast
period, i.e., 2021-2030. The market is estimated
to garner a revenue of USD 142542.43 Million by
the end of 2030, up from a revenue of USD
40982.90 Million in the year 2020. The market is
segmented by screening type into laboratory
tests, genetic tests, imaging, biopsy,
endoscopy, and others. The imaging segment,
amongst all the other segments, is projected to
garner the largest revenue of USD 52365.97
Million by the end of 2030. Additionally, the
segment generated a revenue of USD 15039.41
Million in the year 2020. By country, the Asia
Pacific cancer screening market is segmented into
Australia, Japan, Singapore, South Korea, India,
China, Taiwan, Vietnam, Thailand, Philippines,
and the Rest of Asia Pacific, out of which, the
market in China is anticipated to garner the
largest revenue of USD 62861.21 Million by the
end of 2030. Additionally, the market in the
nation generated a revenue of USD 17376.75
Million in the year 2020. However, the high costs
associated with cancer disease imaging systems,
and the lack of skilled technicians for
performing screening of the disease are
3
some of the major factors predicted to hinder the
market growth in the coming years. This report
also provides the existing competitive scenario
of some of the key players of the Asia Pacific
cancer screening market, which includes company
profiling of Abbott, General Electric, Hologic,
Inc., Siemens Healthcare Private Limited,
QIAGEN, F. Hoffmann-La Roche Ltd., Illumina,
Inc., Novacyt Group, Koninklijke Philips N.V.,
MiRXES Pte Ltd., and others. The profiling
enfolds key information of the companies which
comprises of business overview, products and
services, key financials and recent news and
developments. Conclusively, the report titled
Asia Pacific Cancer Screening Market Demand
Analysis Opportunity Outlook 2030, analyses
the overall Asia Pacific cancer screening
industry to help new entrants to understand the
details of the market. In addition to that, this
report also guides existing players looking for
expansion and major investors looking for
investment in the Asia Pacific cancer screening
market in the near future. Request sample
reporthttps//www.kennethresearch.com/sample-
request-10352360 Kenneth Research is a leading
service provider for strategic market research
and consulting. We aim to provide unbiased,
unparalleled market insights and industry
analysis to help industries, conglomerates and
executives to take wise decisions for their
future marketing strategy, expansion and
investment, etc. We believe every business can
expand to its new horizon, provided a right
guidance at a right time is available through
strategic minds. Our out of box thinking helps
our clients to take wise decision so as to avoid
future uncertainties.
4
Contact for more Info AJ Daniel Email
sales_at_kennethresearch.com U.S. Phone 1 313 462
0609
Write a Comment
User Comments (0)
About PowerShow.com